Insider trades
Pamela Wapnick, CFO of Metagenomi Therapeutics MGX, has filed 0 purchases and 8 sales on the open market. Over the past 12 months that comes to a net sale of $9,068. The latest trade was on 06/05.
Pamela Wapnick
CFO
- Company
- Metagenomi Therapeutics MGX
- First filing
- 24/04/03
- Trades
- 15 trades
- Buys / sales
- 0 / 8
- 12-month net buying
- −$9,068
- Last trade
- 06/05
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 06/05 | 06/10 | 2,884 sh | $1.30 | $3,749.2 | −1.4% | |
| Open-market sale | 03/05 | 03/09 | 1,581 sh | $1.60 | $2,529.6 | −0.8% | |
| Open-market sale | 25/12/05 | 25/12/08 | 1,576 sh | $1.77 | $2,789.52 | −0.8% | |
| Open-market sale | 25/09/05 | 25/12/01 | 1,576 sh | $1.81 | $2,852.56 | −2.2% | |
| Open-market sale | 25/06/06 | 25/06/09 | 1,576 sh | $1.75 | $2,758 | −2.1% | |
| Open-market sale | 25/03/05 | 25/03/07 | 1,808 sh | $1.87 | $3,380.96 | −2.9% | |
| Open-market sale | 24/12/05 | 24/12/06 | 1,559 sh | $1.86 | $2,899.74 | −2.5% | |
| Open-market sale | 24/09/05 | 24/09/06 | 6,265 sh | $2.88 | $18,043.2 | −9.0% |